tm logo

Monitor this mark

View On USPTO

ULTRATRACE
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 21 Oct 2020

Last Applicant/ Owned by

Molecular Insight Pharmaceuticals, Inc.

One World Trade Center

New York

NY

10007

Serial Number

78698536 filed on 23rd Aug 2005

Registration Number

3613887 registered on 28th Apr 2009

in the Principal Register

Correspondent Address

Phi Lan Tinsley

Phi Lan Tinsley

State Street Financial Center

One Lincoln Street

Boston MA 02111

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ULTRATRACE

Radiopharmaceutical preparations for targeted radiotherapy of cancer

Classification Information

Class [005]
Pharmaceutical Products

Radiopharmaceutical preparations for targeted radiotherapy of cancer

First Use Date in General

24th Apr 2006

First Use Date in Commerce

24th Apr 2006

Mark Details

Serial Number

No 78698536

Mark Type

No Service/Collective Mark

Attorney Docket Number

No MIN.606.US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Oct 2020NOTICE OF CANCELLATION SEC. 8 EMAILED
21st Oct 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21st Oct 2020CANCELLED SEC. 8 (10-YR)
16th Sep 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23rd Dec 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 9
07th Dec 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23rd Oct 2019TEAS SECTION 8 & 9 RECEIVED
28th Apr 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05th Jul 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01st Feb 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED